# RNS System LGS Feasibility Study

> **NCT05339126** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **NeuroPace** · enrollment: 24 (estimated)

## Conditions studied

- Epilepsy
- Lennox Gastaut Syndrome
- Lennox-Gastaut Syndrome, Intractable
- Seizures
- Seizures, Generalized

## Interventions

- **DEVICE:** RNS System

## Key facts

- **NCT ID:** NCT05339126
- **Lead sponsor:** NeuroPace
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-04
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339126, "RNS System LGS Feasibility Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05339126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*